RUSSELL MARQUARDT: Open Payments
NPI 1477551661 · HARLAN, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64 in 4 payments from 3 companies in 2025. Trend: 2023 $113 · 2024 $139 · 2025 $64
Food & beverage: $64
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: GARDASIL 9, Wegovy, SHINGRIX, BEXSERO.
Industry payments across IA — which companies pay providers there.
